Merrimack Pharmaceuticals Stock Target Price
Merrimack Pharmaceuticals fundamentals help investors to digest information that contributes to Merrimack Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Merrimack Stock. The fundamental analysis module provides a way to measure Merrimack Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merrimack Pharmaceuticals stock.
Merrimack |
Merrimack Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merrimack Pharmaceuticals' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Merrimack Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Merrimack Pharmaceuticals by comparing valuation metrics of similar companies.Merrimack Pharmaceuticals is currently under evaluation in target price category among its peers.
Merrimack Fundamentals
Return On Equity | -0.0112 | |||
Return On Asset | -0.0107 | |||
Current Valuation | (20.36 M) | |||
Shares Outstanding | 14.79 M | |||
Shares Owned By Insiders | 1.19 % | |||
Shares Owned By Institutions | 62.97 % | |||
Number Of Shares Shorted | 842.49 K | |||
Price To Earning | 65.70 X | |||
Price To Book | 11.38 X | |||
Gross Profit | (9.1 M) | |||
EBITDA | (2.18 M) | |||
Net Income | (1.18 M) | |||
Cash And Equivalents | 13.36 M | |||
Cash Per Share | 1.00 X | |||
Debt To Equity | 33.90 % | |||
Current Ratio | 31.85 X | |||
Book Value Per Share | 15.25 X | |||
Cash Flow From Operations | (1.52 M) | |||
Short Ratio | 8.65 X | |||
Earnings Per Share | (0.09) X | |||
Price To Earnings To Growth | 0.07 X | |||
Target Price | 4.0 | |||
Beta | 1.42 | |||
Market Capitalization | 223.75 M | |||
Total Asset | 19.19 M | |||
Retained Earnings | (548.82 M) | |||
Working Capital | 18.74 M | |||
Current Asset | 89.62 M | |||
Current Liabilities | 88.28 M | |||
Net Asset | 19.19 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Merrimack Stock
If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |